Literature DB >> 30650382

Defining Dysbiosis in Inflammatory Bowel Disease.

Renske J de Jong1, Caspar Ohnmacht2.   

Abstract

In this issue of Immunity, Britton et al. (2019) demonstrate that the colonization of germ-free mice with microbiotas from inflammatory bowel disease patients induces an altered ratio of RORγt+ regulatory T cells to T(h17) effector cells and recapitulates human disease severity in colitis-susceptible mice.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30650382     DOI: 10.1016/j.immuni.2018.12.028

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  3 in total

Review 1.  JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.

Authors:  Azucena Salas; Cristian Hernandez-Rocha; Marjolijn Duijvestein; William Faubion; Dermot McGovern; Severine Vermeire; Stefania Vetrano; Niels Vande Casteele
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-19       Impact factor: 46.802

2.  NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn's disease.

Authors:  Nicolas Rochereau; Xavier Roblin; Eva Michaud; Rémi Gayet; Blandine Chanut; Fabienne Jospin; Blaise Corthésy; Stéphane Paul
Journal:  Nat Commun       Date:  2021-01-11       Impact factor: 14.919

3.  Innovative Animal Model of DSS-Induced Ulcerative Colitis in Pseudo Germ-Free Mice.

Authors:  Sona Gancarcikova; Stanislav Lauko; Gabriela Hrckova; Zuzana Andrejcakova; Vanda Hajduckova; Marian Madar; Livia Kolesar Fecskeova; Dagmar Mudronova; Kristina Mravcova; Gabriela Strkolcova; Radomira Nemcova; Jana Kacirova; Andrea Staskova; Stefan Vilcek; Alojz Bomba
Journal:  Cells       Date:  2020-12-01       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.